Clinical Trial Update: Lentiviral Gene Therapy for CGD [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate a lentiviral gene therapy for Chronic Granulomatous Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• Lentiviral gene therapy for CGD (Lentiviral gene therapy)

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Chronic Granulomatous Disease | NA | Status: RECRUITING